Pliant Therapeutics's total assets for Q4 2025 were $225.23M, a decrease of -18.57% from the previous quarter. PLRX total liabilities were $44.02M for the fiscal quarter, a -42.30% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.